Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Times of India
The Times of India
Lifestyle
IANS

Malaria: New combination drug therapy for children gets first approval

Sydney, A new combination drug therapy against a type of malaria in kids aged 2 to 16 has received the first approval from Australian regulators.

The single dose tafenoquine (Kozenis), administered together with the standard chloroquine therapy, was developed by UK drug major GlaxoSmithKline (GSK) in partnership with nonprofit Medicines for Malaria Venture (MMV).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.